Prostate cancer from the horizon of the patient
Acta Oncologica , Volume 50 - Issue SUPPL. 1 p. 148- 154
The democratization of civil society and the development of modern medicine changed the sacrosanct doctor-patient relationship to a doctor-partner dialogue. Values and respect were lost in the process where common courtesy and empathy in trust were replaced by patient rights. Launch of Europa Uomo. Europa Uomo, the European prostate cancer coalition, represents 22 national, autonomous patient support groups. Its aim includes increasing the awareness of prostate diseases, support individualized treatment as a balance between optimal medical treatment and personalized care delivered by a multiprofessional team. We expect our information/education from dedicated professional societies while in return we share care for properly informed members as well as a fast, unbiased and cheap distribution of information/innovation across the European continent. The role of a patient group. Our advocacy role is focused on quality of life, tailored treatment, knowledge of risk factors, support for research and last but not least active partnerships. We believe that we can play a modest but basic role in common actions to overcome inequalities in treatment and care in Europe. Our responsibilities range from defining patient obligations to facilitating translational research and saving scarce health resources. The horizon of the patient. Our hope is to plead for a treatment policy on the man first and then on his cancer and to improve treatment outcomes by multiprofessional collaboration and the development of expert Prostate Units. Future expectations. A transparent, open communication line between the multiprofessional team and the patient is mandatory. The existing uncertainties should be discussed with common sense but always leave a factor of hope in survival or quality of life.
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Denis, L.J, Roobol-Bouts, M.J, & Dourcy-Belle-Rose, B. (2011). Prostate cancer from the horizon of the patient. Acta Oncologica, 50(SUPPL. 1), 148–154. doi:10.3109/0284186X.2010.528446